https://endpts.com/pfizer-rsv-data-sets-up-10b-showdown-with-gsk-and-moderna-for-the-next-big-vaccine-market/
0
0
4/6/23 at 3:55am
Organization
Endpoints News
Author
Andrew Dunn
The first-ever RSV vaccines are inching closer to reality in what industry executives and analysts anticipate as the start of the next blockbuster vaccine race that could form a $10 billion-plus market. On Wednesday, Pfizer published two papers in the New Eng…
Create an account
or login to join the discussion